Persistent Heparin-Induced Thrombocytopenia Treated With IVIg

Chest. 2017 Sep;152(3):679-680. doi: 10.1016/j.chest.2017.05.044.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Intravenous
  • Anticoagulants / adverse effects*
  • Female
  • Heparin / adverse effects*
  • Humans
  • Immunoglobulins / therapeutic use*
  • Middle Aged
  • Thrombocytopenia* / chemically induced
  • Thrombocytopenia* / drug therapy
  • Treatment Outcome

Substances

  • Anticoagulants
  • Immunoglobulins
  • Heparin